*Details of BioTrinity 2024 to be announced soon*

About BioTrinity

BioTrinity is an established, must-attend London conference, that catalyses growth and supports in-person engagement across the life sciences industry.

The event is attended by an audience of early stage and emerging life sciences R&D companies, investors, big pharma, and other valued partners throughout the life sciences ecosystem. The conference features a focused, relevant, and stimulating programme, led by great speakers, who bring their knowledge, expertise, and vision to the fore in exciting, high-quality sessions.

Interacting with new companies each year is something we believe to be a critical attribute of a successful conference and we work hard to ensure that a substantial and fresh line-up of investable opportunities and collaboration possibilities are showcased.

BioTrinity features:

• A dedicated 'Scientific Track', featuring a focus on eight core therapy areas; Oncology, Neuroscience, Microbiome, Inflammatory Diseases, Rare Diseases, Infectious Diseases, Medtech and Cell & Gene Therapy. Each dedicated session will include an expert update from a key opinion leader, followed by up to 5 showcase presentations from some of the most innovative and interesting R&D companies.
• A second 'life sciences business' focused presentation track, that will feature discussions and keynotes addressing topics from finance and investment, regulatory, government strategy and tax.
• Pre-scheduled live & in-person private partnering meetings during the two-day physical conference as well as a bonus third day of virtual only partnering.
• A sponsors exhibition area and plenty of 'all-delegate' networking opportunities throughout both in-person day, which are so valuable to share knowledge and unlock future collaboration and new business opportunities.
• Option for registered delegates to revisit recorded presentations in the days following the conference.
• BioTrinity Investor Drinks Reception and BioTrinity Networking Party events open to conference delegates.